Krzysztof Strojek

Head

Medical University of Silesia

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Krzysztof Strojek is the Head at the Medical University of Silesia, Poland. His research focuses on diabetes management, atherosclerotic disease treatment, and the clinical implications of different hip endoprosthesis types. He is actively involved in advancing standards of care in diabetes and contributing to interdisciplinary expert team statements addressing complex medical issues.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Michał Dobrakowski

Medical University of Silesia

POLAND

View details

Hanna Kwiendacz

Medical University of Silesia

POLAND

View details

Katarzyna Nabrdalik

UNITED KINGDOM

View details

Leszek Jan Kukulski

Vascular Surgery Trainee/ Teaching Assitant

Wroclaw Medical University

POLAND

View details

Anetta Lasek-Bal

Medical University of Silesia

POLAND

View details

Adam Kobayashi

Professor

Cardinal Stefan Wyszyński University in Warsaw

POLAND

View details

Janusz Gumprecht

Prof

Medical University of Silesia

POLAND

View details

Katarzyna Cypryk

Prof. MD.PhD

POLAND

View details

Sławomir Kasperczyk

POLAND

View details

Alina Ostałowska

Medical University of Silesia

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Krzysztof Strojek

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Continuous glucose monitoring systems can meet the challenge of glucose management and beyond in individuals with type 2 diabetes: an expert multidisciplinary position.

Interdisciplinary expert team statement on the treatment of multi-bed atherosclerotic disease - endorsed by Polish Cardiac Society, Polish Lipid Association, Polish Society of Diabetology, Polish Neurological Society, Polish Society of Nephrology.

The influence of the type of metal-on-metal hip endoprosthesis on the clinical, biochemical, and oxidative balance status - a comparison of resurfacing and metaphyseal implants.

The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes.

Bone graft incorporation failure with inappropriate limb load transfer can lead to aseptic acetabular loosening of metal-on-metal prosthesis: a case report.

Impact of the initiation of isCGM soon after type 1 diabetes mellitus diagnosis in adults on glycemic indices and fear of hypoglycemia: a randomized controlled trial.

Prognostic value of novel atherogenic indices in patients with acute myocardial infarction with and without type 2 diabetes.

Training under normoxia and normobaric hypoxia in patients with type 1 diabetes.

The wedding bells sound really good! iGlarLixi fixed-ratio combination in the treatment of type 2 diabetes: A narrative review.

Metal-on-metal metaphyseal and ceramic-on-ceramic femoral neck arthroplasty: the impact on clinical results, oxidative stress and concentration of metal ions in serum and blood .

Standards of care in diabetes. The position of Diabetes Poland - 2024.

Are there really specific risk factors for heterotopic ossifications? A case report of non-risk factor after total hip replacement.

Antioxidant system and ions concentrations after femoral neck and resurfacing hip arthroplasty.

Carbohydrate metabolism disorders in relation to cardiac allograft vasculopathy (CAV) intensification in heart transplant patients according to the grading scheme developed by the international society for heart and lung transplantation (ISHLT).

Cementless femoral neck endoprosthesis SPIRON in men in aspects of clinical status and quality of life in an average 7-year follow-up.

Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): a randomized, open-label, multinational, phase 3b trial.

Identification of silent myocardial ischemia in patients with long-term type 1 and type 2 diabetes.

Collaborators (10)

Michał Dobrakowski

Hanna Kwiendacz

Katarzyna Nabrdalik

Leszek Jan Kukulski

Anetta Lasek-Bal

Adam Kobayashi

Janusz Gumprecht

Katarzyna Cypryk

Sławomir Kasperczyk

Alina Ostałowska

Make your next move.